Pfizer COVID-19 vaccine appointments are available to our patients. Sign up for Connect today to schedule your vaccination.
Joint Clinical Trials Office
A Gene-Transfer, Open-Label, Dose-Escalation Study of SPK-8011 [Recombinant Adeno-Associated Viral Vector with B-Domain Deleted Human Factor VIII Gene] in Individuals with Hemophilia A
Study Status:
Open to Enrollment
Primary Investigator:
Catherine McGuinn
Date: November 2, 2018
Collection of Airway, Blood, and/or Urine Specimens from Subjects for Research Studies
Study Status:
Open to Enrollment
Primary Investigator:
Crystal, Ronald M.D.
Date: September 22, 2015
Carotid Revascularization and Medical Management for Asymptomatic Carotid Stenosis Trial (CREST-2)
Study Status:
Open to Enrollment
Primary Investigator:
Dana Leifer, M.D.
Date: January 5, 2017
Safety of Immunosuppression in A Prospective Cohort of Inflammatory Bowel Disease Patients With a History of Cancer (SAPPHIRE)
Study Status:
Open to Enrollment
Primary Investigator:
Ellen J. Scherl, M.D.
Date: August 22, 2017
The Multi-Center African American IBD Study (MAAIS)
Study Status:
Open to Enrollment
Primary Investigator:
Ellen Scherl, M.D.
Date: September 22, 2015
A Multicenter National Prospective Study of Pregnancy and Neonatal Outcomes in Women with Inflammatory Bowel Disease
Study Status:
Open to Enrollment
Primary Investigator:
Ellen Scherl, M.D.
Date: September 22, 2015
The Study of Regulatory Cell Number and Function in Patients with Immune Thrombocytopenia (ITP)
Study Status:
Open to Enrollment
Primary Investigator:
Eun-Ju Lee, M.D.
Date: January 6, 2017
PVDOMICS: Defining the Future Fingerprints of Pulmonary Vascular Disease
Study Status:
Open to Enrollment
Primary Investigator:
Evelyn M. Horn, M.D.
Date: February 20, 2017
BP1001 in Combination with Low-dose Cytarabine (LDAC) in Patients with Previously Untreated (AML) Who Are Ineligible for Induction Therapy
Study Status:
Open to Enrollment
Primary Investigator:
Gail J. Roboz, M.D.
Date: April 21, 2017
Phase 3 Randomized Study of the Efficacy and Safety of Posaconazole versus Voriconazole for the Treatment of Invasive Aspergillosis in Adults
Study Status:
Open to Enrollment
Primary Investigator:
Helfgott, David M.D.
Date: September 22, 2015